Crenolanib
- Generic Name
- Crenolanib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H29N5O2
- CAS Number
- 670220-88-9
- Unique Ingredient Identifier
- LQF7I567TQ
- Background
Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
- Associated Conditions
- -
- Associated Therapies
- -
PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 55
- Registration Number
- NCT01393912
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath